- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04327167
Digital Intervention for Ethnic Groups in Transplantation (DIGIT) (DiGiT)
March 27, 2020 updated by: University Hospitals Coventry and Warwickshire NHS Trust
Study Title Digital intervention for Ethnic Groups in Transplantation (DiGiT)
Internal ref. no. (or short title) DiGiT Study Design Observational cohort study Study Participants 90 Planned Size of Sample (if applicable) 30 Follow up duration (if applicable) 2 years Planned Study Period 2 years Research Question/Aim(s)
- To produce, test and pilot a video-based intervention about living donor kidney transplantation in Black, Asian & Minority ethnic (BAME) community in United Kingdom. Embedded within this is an ambassador training.
- Study the long term psychological impact of BAME donors following donation.
Study Overview
Status
Unknown
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
90
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
West Midlands
-
Coventry, West Midlands, United Kingdom
- Recruiting
- Shafi Malik
-
Contact:
- Shafi Malik
- Phone Number: 024 7696 4000
- Email: shafi.malik1@nhs.net
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Adults >18 years of age
- Belong to a BAME community only for phase 1-3, in phase 4 all past and future donors regardless of ethnicity would be eligible.
- Be a community member, past donor, past recipient of a transplant, healthcare professional or be on the waiting list for a transplant.
Exclusion Criteria:
- Anyone less than 18 years of age
- Unable to consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Digital intervention
|
Potential donors would be shown a video and asked to complete a questionnaire to capture change in attitude towards donation.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Magnitude of the change in score assessing knowledge of LDKT by study questionnaire
Time Frame: 2 years
|
Change in attitudes and knowledge of LDKT will be assessed by study questionnaire and the magnitude in change will be quantified by the change in score following digital intervention
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Magnitude of change in QOL score pre donation to 1 year post donation
Time Frame: 2 years
|
Change in QOL as measured by SF 36 in the 3 months preceding donation and 1 year post donation.
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 23, 2019
Primary Completion (Anticipated)
November 30, 2020
Study Completion (Anticipated)
November 30, 2021
Study Registration Dates
First Submitted
December 3, 2019
First Submitted That Met QC Criteria
March 27, 2020
First Posted (Actual)
March 30, 2020
Study Record Updates
Last Update Posted (Actual)
March 30, 2020
Last Update Submitted That Met QC Criteria
March 27, 2020
Last Verified
March 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- IRAS 250798
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Live Donors, Ethnic Minorities, Transplantation
-
University of Colorado, DenverNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Universitair Ziekenhuis BrusselCompletedAdvance Care Planning | Family Caregivers | Ethnic MinoritiesBelgium
-
Universitair Ziekenhuis BrusselCompletedAdvance Care Planning | Ethnic Minorities | Moroccans | Advance Medical Directives | Muslims | Living WillBelgium
-
Universitair Ziekenhuis BrusselCompletedAdvance Care Planning | Ethnic Minorities | Advance Medical Directives | Muslims | Living Will | Turkish OriginBelgium
-
RenJi HospitalCompletedCognitive Development After Pediatric Live TransplantationChina
-
Samsung Medical CenterCompletedKidney Transplantation | Living DonorsKorea, Republic of
-
Gangnam Severance HospitalActive, not recruitingHealthy Donors for Liver TransplantationKorea, Republic of
-
National Cancer Institute (NCI)RecruitingHematopoietic Stem Cell Transplantation | Tissue DonorsUnited States
-
Tehran University of Medical SciencesNot yet recruitingPeri-implant Tissue Stability Following Tissue Augmentation Harvested From Deep Palate or TuberosityTissue Transplantation | Alveolar Ridge Augmentation | Tissue DonorsIran, Islamic Republic of
-
Mayo ClinicNational Institute of Allergy and Infectious Diseases (NIAID)CompletedTransplantation, Kidney | Kidney Transplant Recipients | Living DonorsUnited States
Clinical Trials on Video and questionnaire
-
Democritus University of ThraceRecruitingConcentration Ability Impaired | Sleep Apnea Syndrome, Obstructive | Blinking | Pupil Diameter | DrowsinessGreece
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMalignant Neoplasm | Metastatic Malignant Neoplasm | Advanced Malignant Neoplasm | Recurrent Malignant Neoplasm | Locally Advanced Malignant NeoplasmUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedMalignant Female Reproductive System Neoplasm | CaregiverUnited States
-
Mayo ClinicCompleted
-
M.D. Anderson Cancer CenterCompleted
-
Dana-Farber Cancer InstituteHarvard Medical School (HMS and HSDM); American Cancer Society, Inc.Completed
-
Dr. Mark MulderDelft University of TechnologyRecruitingCancer | Oncology | Facial Expression | Voice | Pain Assessment | Database | Cancer-related Pain | Oncology Pain | Artificial Intelligence (AI)Netherlands
-
Augusta UniversityNot yet recruitingPediatric Kidney DiseaseUnited States
-
Jubilee Mission Medical College and Research InstituteCompleted
-
Chung Shan Medical UniversityMinistry of Education, TaiwanCompletedPneumonia | Asthma | Pleural Effusion | Breathing Sound | AuscultationTaiwan